This inventor holds 2 USPTO granted patents. Top assignee: Riken Corporation. Active years: 2009-2014.
Company Filing History:
Years Active: 2009-2014
Title: Natsuko Matsuda: Innovator in Cell-Free Protein Synthesis
Introduction
Natsuko Matsuda is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of biotechnology, particularly in the area of cell-free protein synthesis. With a total of 2 patents, her work has the potential to revolutionize protein production processes.
Latest Patents
Matsuda's latest patents include a method for cell-free protein synthesis using linear template DNA and a process for producing extracts for cell-free protein synthesis. The first patent describes a simple and efficient process for producing large amounts of protein in a cell-free system. This method utilizes a continuous synthesis reaction over an extended period, employing linear DNA as a template. The synthesis can occur at various temperatures, specifically between 18°C and 36°C, and is ideally suited for dialysis or continuous flow systems. The second patent focuses on improving the productivity and efficiency of protein production by culturing cells under suppressed growth conditions. This innovative approach allows for the collection and disruption of bacterial cells during the stationary phase of culture.
Career Highlights
Natsuko Matsuda is affiliated with Riken Corporation, a leading research institution in Japan. Her work at Riken has allowed her to explore advanced methodologies in protein synthesis, contributing to the scientific community's understanding of cell-free systems.
Collaborations
Matsuda has collaborated with notable colleagues, including Takanori Kigawa and Shigeyuki Yokoyama. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of biotechnology.
Conclusion
Natsuko Matsuda's contributions to cell-free protein synthesis exemplify her innovative spirit and dedication to advancing biotechnology. Her patents reflect a commitment to improving protein production processes, which could have far-reaching implications in various industries.